StonvexLoading…
StonvexStonvexStonvexCore line items from BLMN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-29 | Annual 2024 2024-09-29 | Annual 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $3.96B | $3.95B | $910.01M | $999.37M |
Operating Income | $37.16M | $139.81M | $8.64M | $44.05M |
Net Income | $8.24M | $-128.02M | Not available | Not available |
EPS (Diluted) | $0.10 | $-1.49 | $-0.01 | $0.28 |
Total Assets | $3.17B | $3.38B | Not available | Not available |
Total Liabilities | $2.83B | $3.25B | Not available | Not available |
Cash & Equivalents | $59.46M | $70.06M | Not available | Not available |
Free Cash Flow OCF − CapEx | $96.77M | $7.39M | Not available | Not available |
Shares Outstanding | 85.22M | 84.85M | Not available | Not available |